Skip to content

The role of STRA6 induced by ONECUT2 drives malignant progression and radioresistance in rectal cancer through activating the Wnt/β-Catenin signaling pathway

Jul 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 38 references
Medicine

TL;DR

STRA6’s function was clarified and ONECUT2 was identified as its upstream transcription factor regulating the Wnt/β-catenin pathway to facilitate RC progression and radiation resistance and provide novel insights into the prognostic and functional role of STRA6.

View source

Similar papers

Jul 2026

GATA6-mediated transcriptional activation and METTL3/IGF2BP2-dependent post-transcriptional stabilization upregulate CDC20 to promote the malignant progression of colorectal cancer and immune escape

CDC20, upregulated transcriptionally by GATA6 and post-transcriptionally by METTL3, drove CRC progression, angiogenesis, and immune evasion and reversed the inhibitory effects of METTL3 knockdown on CRC cell malignancy and immune escape.

Yuyu Wang, Xinfei Wang, Yongsheng Chang et al. · 0 citations
Open access Jul 2026

HNRNPA0 Acts as a Master Upstream Regulator of NF-κB to Drive Oncogenic Phenotypes in Oral Squamous Cell Carcinoma

Background Oral squamous cell carcinoma (OSCC) remains a lethal malignancy with a 5-year survival rate below 50%, necessitating the identification of novel therapeutic targets. While the RNA-binding protein HNRNPA0 is implicated in various cancers, its precise role and mechanism in OSCC pathogenesis are undefined. Meth...

Hong Zang, Wei Wang, Bo-Wen Zhao et al. · 0 citations
Open access Jul 2026

LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer

RASAL2-AS1 exerts a tumor-suppressive effect in cervical cancer by functioning as a competing endogenous RNA (ceRNA) that modulates the miR-590-5p/PDCD5 axis and regulates the Wnt/β-catenin pathway.

Ke Yin, Yi Li, Mengying Tang · 0 citations
Open access Jul 2026

KLF14 inhibits EMT in esophageal cancer cells through inhibition of the MISP-Wnt/β-catenin signaling axis

It is demonstrated that KLF14 can inhibit ESCC EMT at least partially via downregulating MISP expression to block downstream Wnt/β-catenin signaling and suggest MISP as a potential therapeutic target for related malignancies.

Xiao-Bo Chen, Jia-Zhu Wang, Dong-Mei Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.